The tech giant’s Damo Academy secured a “breakthrough device” designation from the US regulator for its pancreatic cancer-detecting AI model, Damo Panda
The FDA granted the “breakthrough device” designation to the research group’s Damo Panda model, allowing for an expedited review and approval process, Alibaba said in a statement on Thursday. Alibaba owns the South China Morning Post.